跳至主要内容
临床试验/NL-OMON33978
NL-OMON33978尚未招募不适用

The airway smooth muscle cell in asthma: A genomics approach - Genomics in asthma

Academisch Medisch Centrum0 个研究点目标入组 48 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
48

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Asthmatic patients :
  • - Age between 18 * 50 years
  • - History of episodic chest tightness and wheezing
  • - Intermittent or mild persistent asthma according to the criteria by the Global Initiative for Asthma
  • - Non-smoking or stopped smoking more than 12 months ago and 5 pack years or less
  • - Clinically stable, no exacerbations within the last 6 weeks prior to the study. Occasional usage of inhaled short-acting Beta2-agonists as rescue medication is allowed, prior and during the study.
  • - Steroid-naïve or those patients who are currently not on corticosteroids and have not taken any corticosteroids by any dosing-routes within 8 weeks prior to the study
  • - Baseline FEV1 >70% of predicted
  • - Airway hyperresponsiveness, indicated by a positive methacholine challenge with PC20 <8mg/ml
  • - Positive skin prick test (SPT) to one or more of the 12 common aeroallergen extracts, defined as a wheal >3mm in diameter;Healthy, non-asthmatic patients are recruited using the following inclusion criteria:
  • - Age between 18 * 50 years
  • - Non-smoking or stopped smoking more than 12 months and 5 pack years or less
  • - Baseline FEV1 >70% of predicted
  • - Negative methacholine challenge or PC20 >8mg/ml
  • - No usage of steroids by any dosing route
  • Additionally, non-asthmatic non-allergic patients must have a negative skin prick test (SPT) to one of the 12 common aeroallergen extracts, whereas non-asthmatic allergic patients must have a positive SPT.;Regarding confirming the feasibility of RNA-analysis:
  • - Chronic cough patients who are scheduled to undergo a routine, diagnostic bronchoscopy with biopsy collection.

排除标准

  • - History of clinical significant hypotensive episodes or symptoms of fainting, dizziness, or light-headedness
  • - Women who are pregnant or lactating or who have a positive urine pregnancy test at screening
  • - Chronic use of any other medication for treatment of lung disease other than short-acting Beta2-agonists
  • - Ongoing use of tobacco products of any kind or previous usage with a total pack year of 6 or greater

研究者

相似试验